Compare
Innovative Eyewear Inc vs RxSight, Inc. vs Staar Surgical Co vs Warby Parker Inc.
| Latest fiscal year | Innovative Eyewear Inc LUCYW | RxSight, Inc. RXST | Staar Surgical Co STAA | Warby Parker Inc. WRBY |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-01-02 | 2025-12-31 |
| Revenue | $2.66M | $134.48M | $239.44M | $871.90M |
| Revenue growth (YoY) | +62.6% | -3.9% | -23.7% | +13.0% |
| Gross margin | 21.3% | 76.6% | 76.2% | 54.0% |
| Operating margin | n/a | -35.8% | -38.3% | -0.6% |
| Net margin | -285.2% | -29.0% | -33.6% | 0.2% |
| Net income | -$7.59M | -$38.94M | -$80.45M | $1.64M |
| EPS (Diluted) | -$1.90 | -$0.95 | -$1.62 | $0.01 |
| Operating cash flow | -$7.28M | -$15.51M | -$34.23M | $110.78M |
| Free cash flow | -$7.35M | -$19.34M | -$40.05M | $43.74M |
| Cash & equivalents | $6.51M | $19.95M | $153.15M | $286.36M |
| Total assets | $10.14M | $311.81M | $451.68M | $720.92M |
| Total liabilities | $1.07M | $36.13M | $107.49M | $353.19M |
| Shareholders' equity | $9.07M | $275.68M | $344.18M | $367.73M |
| Return on year-end equity | -83.7% | -14.1% | -23.4% | 0.4% |
| Shares outstanding | 5.48M | 41.24M | 49.40M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Innovative Eyewear Inc | RxSight, Inc. | Staar Surgical Co | Warby Parker Inc. |
|---|---|---|---|---|
| Latest | $2.66M Ended 2025-12-31 | $134.48M Ended 2025-12-31 | $239.44M Ended 2026-01-02 | $871.90M Ended 2025-12-31 |
| 1 year earlier | $1.64M Ended 2024-12-31 | $139.93M Ended 2024-12-31 | $313.90M Ended 2024-12-27 | $771.32M Ended 2024-12-31 |
| 2 years earlier | $1.15M Ended 2023-12-31 | $89.08M Ended 2023-12-31 | $322.42M Ended 2023-12-29 | $669.76M Ended 2023-12-31 |
| 3 years earlier | $659.8K Ended 2022-12-31 | $49.01M Ended 2022-12-31 | $239.44M Ended 2022-12-30 | $598.11M Ended 2022-12-31 |
| 4 years earlier | $690.7K Ended 2021-12-31 | $22.59M Ended 2021-12-31 | $230.47M Ended 2021-12-31 | $540.80M Ended 2021-12-31 |